Form D · Other Health Care
Bioarray Genetics, Inc.
Farmington, CT · CIK 0001641015
Offering snapshot reported Sep 26, 2017 · SEC filing
- Reported sold
- $5.22M Offering amount: $5.22M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 18, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2017 | Initial | $5,217,324 | No comparison | 20 | SEC filing |
| May 1, 2015 | Initial | $1,468,163 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295381
Source: Form D, filed Sep 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zafrira Avnur | Director |
| Marcia Fournier | Director, Executive |
| Henry Kay | Director |
| Jim La France | Director |
| Pamela Layton | Director, Executive |
| Pauline Murphy | Director |
| Patrick O'neill | Director |
| Michael Preminger | Director |
| Michal Preminger | Director |
| Una Ryan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
400 Farmington Avenue
Farmington, CT, 06032
Farmington, CT, 06032